A citation-based method for searching scientific literature

Simon Mallal, Elizabeth Phillips, Giampiero Carosi, Jean-Michel Molina, Cassy Workman, Janez Tomazic, Eva Jägel-Guedes, Sorin Rugina, Oleg Kozyrev, Juan Flores Cid, Phillip Hay, David Nolan, Sara Hughes, Arlene Hughes, Susanna Ryan, Nicholas Fitch, Daren Thorborn, Alastair Benbow. N Engl J Med 2008
Times Cited: 1136







List of co-cited articles
1040 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.
S Mallal, D Nolan, C Witt, G Masel, A M Martin, C Moore, D Sayer, A Castley, C Mamotte, D Maxwell,[...]. Lancet 2002
922
30

Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.
Patricia T Illing, Julian P Vivian, Nadine L Dudek, Lyudmila Kostenko, Zhenjun Chen, Mandvi Bharadwaj, John J Miles, Lars Kjer-Nielsen, Stephanie Gras, Nicholas A Williamson,[...]. Nature 2012
429
28

Medical genetics: a marker for Stevens-Johnson syndrome.
Wen-Hung Chung, Shuen-Iu Hung, Hong-Shang Hong, Mo-Song Hsih, Li-Cheng Yang, Hsin-Chun Ho, Jer-Yuarn Wu, Yuan-Tsong Chen. Nature 2004
28

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
Ann K Daly, Peter T Donaldson, Pallav Bhatnagar, Yufeng Shen, Itsik Pe'er, Aris Floratos, Mark J Daly, David B Goldstein, Sally John, Matthew R Nelson,[...]. Nat Genet 2009
653
23

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.
David A Ostrov, Barry J Grant, Yuri A Pompeu, John Sidney, Mikkel Harndahl, Scott Southwood, Carla Oseroff, Shun Lu, Jean Jakoncic, Cesar Augusto F de Oliveira,[...]. Proc Natl Acad Sci U S A 2012
247
22

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.
Shuen-Iu Hung, Wen-Hung Chung, Lieh-Bang Liou, Chen-Chung Chu, Marie Lin, Hsien-Ping Huang, Yen-Ling Lin, Joung-Liang Lan, Li-Cheng Yang, Hong-Shang Hong,[...]. Proc Natl Acad Sci U S A 2005
781
21

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.
Seth Hetherington, Arlene R Hughes, Michael Mosteller, Denise Shortino, Katherine L Baker, William Spreen, Eric Lai, Kirstie Davies, Abigail Handley, David J Dow,[...]. Lancet 2002
560
20

High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.
Michael Saag, Rukmini Balu, Elizabeth Phillips, Philip Brachman, Claudia Martorell, William Burman, Britt Stancil, Michael Mosteller, Cindy Brothers, Paul Wannamaker,[...]. Clin Infect Dis 2008
262
19

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.
Mark McCormack, Ana Alfirevic, Stephane Bourgeois, John J Farrell, Dalia Kasperavičiūtė, Mary Carrington, Graeme J Sills, Tony Marson, Xiaoming Jia, Paul I W de Bakker,[...]. N Engl J Med 2011
575
18

Identification of drug-specific public TCR driving severe cutaneous adverse reactions.
Ren-You Pan, Mu-Tzu Chu, Chuang-Wei Wang, Yun-Shien Lee, Francois Lemonnier, Aaron W Michels, Ryan Schutte, David A Ostrov, Chun-Bing Chen, Elizabeth Jane Phillips,[...]. Nat Commun 2019
37
48

Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.
Pei Chen, Juei-Jueng Lin, Chin-Song Lu, Cheung-Ter Ong, Peiyuan F Hsieh, Chih-Chao Yang, Chih-Ta Tai, Shey-Lin Wu, Cheng-Hsien Lu, Yung-Chu Hsu,[...]. N Engl J Med 2011
411
17

Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury.
Manal M Monshi, Lee Faulkner, Andrew Gibson, Rosalind E Jenkins, John Farrell, Caroline J Earnshaw, Ana Alfirevic, Karin Cederbrant, Ann K Daly, Neil French,[...]. Hepatology 2013
150
15

HLA-B*13:01 and the dapsone hypersensitivity syndrome.
F-R Zhang, H Liu, A Irwanto, X-A Fu, Y Li, G-Q Yu, Y-X Yu, M-F Chen, H-Q Low, J-H Li,[...]. N Engl J Med 2013
149
15

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
Annalise M Martin, David Nolan, Silvana Gaudieri, Coral Ann Almeida, Richard Nolan, Ian James, Filipa Carvalho, Elizabeth Phillips, Frank T Christiansen, Anthony W Purcell,[...]. Proc Natl Acad Sci U S A 2004
327
14

Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.
Diana Chessman, Lyudmila Kostenko, Tessa Lethborg, Anthony W Purcell, Nicholas A Williamson, Zhenjun Chen, Lars Kjer-Nielsen, Nicole A Mifsud, Brian D Tait, Rhonda Holdsworth,[...]. Immunity 2008
219
13

A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.
Marco Cardone, Karla Garcia, Mulualem E Tilahun, Lisa F Boyd, Sintayehu Gebreyohannes, Masahide Yano, Gregory Roderiquez, Adovi D Akue, Leslie Juengst, Elliot Mattson,[...]. J Clin Invest 2018
25
52

Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
Wen-Hung Chung, Wan-Chun Chang, Yun-Shien Lee, Ying-Ying Wu, Chih-Hsun Yang, Hsin-Chun Ho, Ming-Jing Chen, Jing-Yi Lin, Rosaline Chung-Yee Hui, Ji-Chen Ho,[...]. JAMA 2014
166
13

Abacavir-reactive memory T cells are present in drug naïve individuals.
Andrew Lucas, Michaela Lucas, Anette Strhyn, Niamh M Keane, Elizabeth McKinnon, Rebecca Pavlos, Ellen M Moran, Viola Meyer-Pannwitt, Silvana Gaudieri, Lloyd D'Orsogna,[...]. PLoS One 2015
56
21

Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles.
M Isabel Lucena, Mariam Molokhia, Yufeng Shen, Thomas J Urban, Guruprasad P Aithal, Raúl J Andrade, Christopher P Day, Francisco Ruiz-Cabello, Peter T Donaldson, Camilla Stephens,[...]. Gastroenterology 2011
277
12

Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01.
James Yun, Maria J Marcaida, Klara K Eriksson, Heidi Jamin, Stefano Fontana, Werner J Pichler, Daniel Yerly. J Immunol 2014
100
12

HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms.
Katherine C Konvinse, Jason A Trubiano, Rebecca Pavlos, Ian James, Christian M Shaffer, Cosmin A Bejan, Ryan J Schutte, David A Ostrov, Mark A Pilkinton, Misha Rosenbach,[...]. J Allergy Clin Immunol 2019
50
24

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir.
S Hetherington, S McGuirk, G Powell, A Cutrell, O Naderer, B Spreen, S Lafon, G Pearce, H Steel. Clin Ther 2001
297
11

Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Wen-Hung Chung, Shuen-Iu Hung, Jui-Yung Yang, Shih-Chi Su, Shien-Ping Huang, Chun-Yu Wei, See-Wen Chin, Chien-Chun Chiou, Sung-Chao Chu, Hsin-Chun Ho,[...]. Nat Med 2008
439
11

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.
Takeshi Ozeki, Taisei Mushiroda, Amara Yowang, Atsushi Takahashi, Michiaki Kubo, Yuji Shirakata, Zenro Ikezawa, Masafumi Iijima, Tetsuo Shiohara, Koji Hashimoto,[...]. Hum Mol Genet 2011
336
11

Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
Chun-Yu Wei, Wen-Hung Chung, Hsiao-Wen Huang, Yuan-Tsong Chen, Shuen-Iu Hung. J Allergy Clin Immunol 2012
179
11

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.
Christine Lonjou, Nicolas Borot, Peggy Sekula, Neil Ledger, Laure Thomas, Sima Halevy, Luigi Naldi, Jan-Nico Bouwes-Bavinck, Alexis Sidoroff, Claudia de Toma,[...]. Pharmacogenet Genomics 2008
397
11

HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis.
E Genin, D-P Chen, S-I Hung, P Sekula, M Schumacher, P-Y Chang, S-H Tsai, T-L Wu, T Bellón, R Tamouza,[...]. Pharmacogenomics J 2014
140
11

Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity.
Dyfrig A Hughes, F Javier Vilar, Charlotte C Ward, Ana Alfirevic, B Kevin Park, Munir Pirmohamed. Pharmacogenetics 2004
186
10

Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
Shuen-Iu Hung, Wen-Hung Chung, Zhi-Sheng Liu, Chien-Hsiun Chen, Mo-Song Hsih, Rosaline Chung-yee Hui, Chia-Yu Chu, Yuan-Tsong Chen. Pharmacogenomics 2010
186
10

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
Chaichon Locharernkul, Jakrin Loplumlert, Chusak Limotai, Wiwat Korkij, Tayard Desudchit, Siraprapa Tongkobpetch, Oratai Kangwanshiratada, Nattiya Hirankarn, Kanya Suphapeetiporn, Vorasuk Shotelersuk. Epilepsia 2008
305
10

Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.
Chun-Bing Chen, Yi-Hsin Hsiao, Tony Wu, Mo-Song Hsih, Wichittra Tassaneeyakul, Teekayu P Jorns, Chonlaphat Sukasem, Chien-Ning Hsu, Shih-Chi Su, Wan-Chun Chang,[...]. Neurology 2017
68
14

Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.
Wen-Hung Chung, Ren-You Pan, Mu-Tzu Chu, See-Wen Chin, Yu-Lin Huang, Wei-Chi Wang, Jen-Yun Chang, Shuen-Iu Hung. J Invest Dermatol 2015
70
14

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations.
Faviel F González-Galarza, Louise Y C Takeshita, Eduardo J M Santos, Felicity Kempson, Maria Helena Thomaz Maia, Andrea Luciana Soares da Silva, André Luiz Teles e Silva, Gurpreet S Ghattaoraya, Ana Alfirevic, Andrew R Jones,[...]. Nucleic Acids Res 2015
528
9

Idiosyncratic adverse drug reactions: current concepts.
Jack Uetrecht, Dean J Naisbitt. Pharmacol Rev 2013
161
9

Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans.
Sae-Hoon Kim, Kyung Wha Lee, Woo-Jung Song, Sang-Heon Kim, Young-Koo Jee, Sang-Min Lee, Hye-Ryun Kang, Heung-Woo Park, Sang-Heon Cho, Seong-Ho Park,[...]. Epilepsy Res 2011
165
9

Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population.
Therdpong Tempark, Patompong Satapornpong, Pawinee Rerknimitr, Nontaya Nakkam, Niwat Saksit, Penpun Wattanakrai, Thawinee Jantararoungtong, Napatrupron Koomdee, Ajanee Mahakkanukrauh, Wichittra Tassaneeyakul,[...]. Pharmacogenet Genomics 2017
43
20

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study.
Tai-Ming Ko, Chang-Youh Tsai, Shih-Yang Chen, Kuo-Shu Chen, Kuang-Hui Yu, Chih-Sheng Chu, Chung-Ming Huang, Chrong-Reen Wang, Chia-Tse Weng, Chia-Li Yu,[...]. BMJ 2015
108
9

HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer.
Colin F Spraggs, Laura R Budde, Linda P Briley, Nan Bing, Charles J Cox, Karen S King, John C Whittaker, Vincent E Mooser, Alaknanda J Preston, Steven H Stein,[...]. J Clin Oncol 2011
192
8

Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.
Michael A Norcross, Shen Luo, Li Lu, Michael T Boyne, Mary Gomarteli, Aaron D Rennels, Janet Woodcock, David H Margulies, Curtis McMurtrey, Stephen Vernon,[...]. AIDS 2012
146
8

T-cells from HLA-B*57:01+ human subjects are activated with abacavir through two independent pathways and induce cell death by multiple mechanisms.
Catherine C Bell, Lee Faulkner, Klara Martinsson, John Farrell, Ana Alfirevic, Jonathan Tugwood, Munir Pirmohamed, Dean J Naisbitt, B Kevin Park. Chem Res Toxicol 2013
37
21

Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
Tai-Ming Ko, Wen-Hung Chung, Chun-Yu Wei, Han-Yu Shih, Jung-Kuei Chen, Chia-Hsien Lin, Yuan-Tsong Chen, Shuen-Iu Hung. J Allergy Clin Immunol 2011
166
8

Delayed drug hypersensitivity reactions.
Werner J Pichler. Ann Intern Med 2003
430
8


T cell-mediated hypersensitivity reactions to drugs.
Rebecca Pavlos, Simon Mallal, David Ostrov, Soren Buus, Imir Metushi, Bjoern Peters, Elizabeth Phillips. Annu Rev Med 2015
77
10

Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin.
Wen-Hung Chung, Wan-Chun Chang, Sophie L Stocker, Chiun-Gung Juo, Garry G Graham, Ming-Han H Lee, Kenneth M Williams, Ya-Chung Tian, Kuo-Chang Juan, Yeong-Jian Jan Wu,[...]. Ann Rheum Dis 2015
119
8

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
Wichittra Tassaneeyakul, Thawinee Jantararoungtong, Pei Chen, Pao-Yu Lin, Somsak Tiamkao, Usanee Khunarkornsiri, Pachadaporn Chucherd, Parinya Konyoung, Suda Vannaprasaht, Charoen Choonhakarn,[...]. Pharmacogenet Genomics 2009
248
8


Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans.
Hye-Ryun Kang, Young Koo Jee, Yon-Soo Kim, Chang Hwa Lee, Jae-Woo Jung, Sae Hoon Kim, Heung-Woo Park, Yoon-Seok Chang, In-Jin Jang, Sang-Heon Cho,[...]. Pharmacogenet Genomics 2011
143
8


Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.
Katie D White, Wen-Hung Chung, Shuen-Iu Hung, Simon Mallal, Elizabeth J Phillips. J Allergy Clin Immunol 2015
126
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.